Sofinnova Investments, Inc.
Filing Date
Global Rank
#1,353
/ 8,700
▼ 109
Top Industry
Biotechnology
62.7%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
55 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
21.8%
+10.0 pts
Top 5
42.4%
+9.8 pts
Top 10
58.8%
+7.8 pts
HHI
703
Diversified+306
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,933,731,887 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GMAB | Genmab A/S | +3,292,954 | 4,045,215 | $111,122,056 | |
| TENX | Tenax Therapeutics, Inc. | +395,639 | 500,039 | $7,275,567 | |
| ANAB | Anaptysbio, Inc | +245,283 | 493,536 | $33,313,680 | |
| OKUR | OnKure Therapeutics, Inc. | +179,992 | 321,692 | $1,466,915 | |
| SUPN | Supernus Pharmaceuticals, Inc. | +82,019 | 1,036,328 | $48,199,615 | |
| MANE | Veradermics, Inc | +75,678 | 148,993 | $18,317,199 | |
| IRON | Disc Medicine, Inc. | +67,919 | 146,239 | $10,695,920 | |
| PHVS | Pharvaris N.V. | +62,971 | 881,299 | $30,475,319 | |
| IMTX | Immatics N.V. | +38,892 | 3,669,346 | $37,170,474 | |
| DYN | Dyne Therapeutics, Inc. | +24,487 | 1,658,384 | $36,832,708 | |
| RCUS | Arcus Biosciences, Inc. | +22,604 | 945,690 | $29,155,622 | |
| IMNM | Immunome Inc. | +18,412 | 1,720,316 | $36,453,496 | |
| EXEL | Exelixis, Inc. | +2,700 | 254,200 | $13,831,022 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | −1,278,383 | 2,217,505 | $74,042,491 | |
| BMY | Bristol Myers Squibb Co | −1,111,751 | 876,970 | $50,531,011 | |
| COGT | Cogent Biosciences, Inc. | −1,078,403 | 1,035,148 | $40,060,227 | |
| ALC | Alcon Inc | −474,148 | 255,824 | $17,165,790 | |
| BMRN | Biomarin Pharmaceutical Inc | −423,414 | 358,568 | $20,517,260 | |
| AXSM | Axsome Therapeutics, Inc. | −252,318 | 160,429 | $39,268,206 | |
| JAZZ | Jazz Pharmaceuticals plc | −232,986 | 365,341 | $88,036,220 | |
| IDYA | IDEAYA Biosciences, Inc. | −206,667 | 925,119 | $34,479,185 | |
| INSM | INSMED Inc | −187,677 | 158,398 | $16,888,394 | |
| TYRA | Tyra Biosciences, Inc. | −171,748 | 32,267 | $1,030,607 | |
| UTHR | UNITED THERAPEUTICS Corp | −163,881 | 76,489 | $41,444,034 | |
| INBX | Inhibrx Biosciences, Inc. | −102,926 | 303,103 | $28,719,009 | |
| DFTX | Definium Therapeutics, Inc. | −88,263 | 255,903 | $12,037,677 | |
| PRAX | Praxis Precision Medicines, Inc. | −57,240 | 6,440 | $2,156,047 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −42,069 | 408,027 | $45,303,237 | |
| NKTR | Nektar Therapeutics | −37,783 | 471,763 | $32,933,775 | |
| EWTX | Edgewise Therapeutics, Inc. | −5,575 | 380,923 | $15,476,901 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
13 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SPTX | Seaport Therapeutics, Inc. | 3,564,871 | $77,428,998 | |
| GILD | Gilead Sciences, Inc. | 343,100 | $43,347,254 | |
| ISRG | Intuitive Surgical Inc | 40,000 | $15,907,200 | |
| GMED | Globus Medical Inc | 200,000 | $15,802,000 | |
| NRIX | Nurix Therapeutics, Inc. | 524,098 | $12,714,617 | |
| DSGN | Design Therapeutics, Inc. | 865,135 | $12,518,503 | |
| TRAX | First Tracks Biotherapeutics, Inc. | 565,199 | $11,371,803 | |
| ABT | Abbott Laboratories | 122,998 | $11,160,838 | |
| SION | Sionna Therapeutics, Inc. | 144,432 | $6,353,563 | |
| ABSI | Absci Corp | 337,400 | $3,910,466 | |
| SGMT | Sagimet Biosciences Inc. | 166,667 | $1,288,335 | |
| AKTS | Aktis Oncology, Inc. | 32,436 | $1,045,412 | |
| HTFL | Heartflow, Inc. | 5,079 | $149,017 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AAXJ | iShares MSCI All Country Asia ex Japan ETF | 600,000 | $148,800,000 | |
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 1,050,000 | $134,116,500 | |
| AZN | Astrazeneca PLC | 456,031 | $89,938,433 | |
| QQQ | Invesco Qqq Trust, Series 1 | 150,000 | $86,577,000 | |
| — | 475,000 | $80,203,750 | ||
| CELC | Celcuity Inc. | 666,175 | $76,037,214 | |
| BIIB | Biogen Inc. | 229,521 | $42,078,084 | |
| BBIO | BridgeBio Pharma, Inc. | 409,183 | $30,385,929 | |
| DXCM | Dexcom Inc | 393,576 | $24,716,572 | |
| PFE | Pfizer Inc | 800,000 | $22,464,000 | |
| LQDA | Liquidia Corp | 500,000 | $18,870,000 | |
| XENE | Xenon Pharmaceuticals Inc. | 305,216 | $17,748,310 | |
| SYK | Stryker Corp | 44,480 | $14,615,683 | |
| CMPX | Compass Therapeutics, Inc. | 2,556,161 | $13,522,091 | |
| ROIV | Roivant Sciences Ltd. | 477,995 | $13,240,461 | |
| ORIC | Oric Pharmaceuticals, Inc. | 679,578 | $8,610,253 | |
| TNGX | Tango Therapeutics, Inc. | 395,081 | $8,265,094 | |
| REPL | Replimune Group, Inc. | 1,015,400 | $7,767,810 | |
| AXGN | Axogen, Inc. | 210,665 | $6,979,331 | |
| CYTK | Cytokinetics Inc | 91,791 | $6,049,944 | |
| HRMY | Harmony Biosciences Holdings, Inc. | 152,695 | $4,276,986 | |
| PCVX | Vaxcyte, Inc. | 50,600 | $2,940,366 | |
| ESTA | Establishment Labs Holdings Inc. | 33,930 | $1,926,545 | |
| ACAD | Acadia Pharmaceuticals Inc | 78,551 | $1,748,545 | |
| ZYME | Zymeworks Inc. | 1,610 | $40,314 | |
| No positions match the current search. | ||||
55 tracked positions ·
$1,933,731,887 total
· filing declares
57 positions · $1,934,262,135
· as of Jun 30, 2026
Showing 1–50
of 55 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NTRA |
Natera, Inc.
Healthcare
|
Held | 1,550,280 | $420,823,506 | 21.76% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 2,793,987 | $119,889,982 | 6.20% | |
| GMAB |
Genmab A/S
Healthcare
|
Added | 4,045,215 | $111,122,056 | 5.75% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Reduced | 365,341 | $88,036,220 | 4.55% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 1,904,408 | $79,356,681 | 4.10% | |
| SPTX |
Seaport Therapeutics, Inc.
Healthcare
|
NEW | 3,564,871 | $77,428,998 | 4.00% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 2,217,505 | $74,042,491 | 3.83% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Held | 1,696,752 | $58,945,164 | 3.05% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
Held | 2,293,788 | $56,220,743 | 2.91% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Reduced | 876,970 | $50,531,011 | 2.61% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
Added | 1,036,328 | $48,199,615 | 2.49% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 408,027 | $45,303,237 | 2.34% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
NEW | 343,100 | $43,347,254 | 2.24% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 76,489 | $41,444,034 | 2.14% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 1,035,148 | $40,060,227 | 2.07% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 160,429 | $39,268,206 | 2.03% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 3,669,346 | $37,170,474 | 1.92% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 1,658,384 | $36,832,708 | 1.90% | |
| IMNM |
Immunome Inc.
Healthcare
|
Added | 1,720,316 | $36,453,496 | 1.89% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Reduced | 925,119 | $34,479,185 | 1.78% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Added | 493,536 | $33,313,680 | 1.72% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Reduced | 471,763 | $32,933,775 | 1.70% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 881,299 | $30,475,319 | 1.58% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Added | 945,690 | $29,155,622 | 1.51% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
Reduced | 303,103 | $28,719,009 | 1.49% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 358,568 | $20,517,260 | 1.06% | |
| MANE |
Veradermics, Inc
Healthcare
|
Added | 148,993 | $18,317,199 | 0.95% | |
| ALC |
Alcon Inc
Healthcare
|
Reduced | 255,824 | $17,165,790 | 0.89% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 158,398 | $16,888,394 | 0.87% | |
| ISRG |
Intuitive Surgical Inc
CALL
Healthcare
|
NEW | 40,000 | $15,907,200 | 0.82% | |
| GMED |
Globus Medical Inc
CALL
Healthcare
|
NEW | 200,000 | $15,802,000 | 0.82% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 380,923 | $15,476,901 | 0.80% | |
| EXEL |
Exelixis, Inc.
PUT
Healthcare
|
Added | 254,200 | $13,831,022 | 0.72% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 524,098 | $12,714,617 | 0.66% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
NEW | 865,135 | $12,518,503 | 0.65% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Reduced | 255,903 | $12,037,677 | 0.62% | |
| TRAX |
First Tracks Biotherapeutics, Inc.
Healthcare
|
NEW | 565,199 | $11,371,803 | 0.59% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 122,998 | $11,160,838 | 0.58% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 146,239 | $10,695,920 | 0.55% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Added | 500,039 | $7,275,567 | 0.38% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
NEW | 144,432 | $6,353,563 | 0.33% | |
| ABSI |
Absci Corp
Healthcare
|
NEW | 337,400 | $3,910,466 | 0.20% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Held | 27,591 | $3,230,078 | 0.17% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 107,391 | $2,386,228 | 0.12% | |
| SVRA |
Savara Inc
Healthcare
|
Held | 364,763 | $2,246,940 | 0.12% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 6,440 | $2,156,047 | 0.11% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 47,506 | $1,590,975 | 0.08% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Added | 321,692 | $1,466,915 | 0.08% | |
| SGMT |
Sagimet Biosciences Inc.
Healthcare
|
NEW | 166,667 | $1,288,335 | 0.07% | |
| WVE |
Wave Life Sciences, Inc.
Healthcare
|
Held | 189,253 | $1,099,559 | 0.06% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.